SEI INVESTMENTS CO

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 350894 OAKS, PA

Position in CRNX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,686,262

-$667,431 QoQ

Shares Held

73,961

+2.7% QoQ

Ownership

0.070%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SEI INVESTMENTS CO holds $1,293,395,418 across 195 Biotechnology names. CRNX ranks #50 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	1,395,794	$228,240,234
2	ARGX	Argenx SE	286,966	$209,556,920
3	ASND	Ascendis Pharma A/S	351,146	$80,317,623
4	EXEL	Exelixis, Inc.	1,629,670	$69,896,545
5	INCY	Incyte Corp	714,558	$67,254,197
6	VRTX	Vertex Pharmaceuticals Inc / Ma	133,226	$59,490,737
7	REGN	Regeneron Pharmaceuticals, Inc.	75,000	$57,947,999
8	ALNY	Alnylam Pharmaceuticals, Inc.	100,315	$33,191,223

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,686,262	73,961	+2.7%	Shares	Sole	2026-05-13
2025-12-31	$3,353,693	72,045	+19.4%	Shares	Sole	2026-02-13
2025-09-30	$2,513,160	60,340	+0.3%	Shares	Sole	2025-11-13
2025-06-30	$1,730,776	60,180	+10.0%	Shares	Sole	2025-08-14
2025-03-31	$1,835,107	54,714	-1.8%	Shares	Sole	2025-05-14
2024-12-31	$2,849,321	55,727	-0.8%	Shares	Defined	2025-02-11
2024-09-30	$2,869,571	56,156	+51.9%	Shares	Defined	2024-11-12
2024-06-30	$1,656,020	36,973	+24.6%	Shares	Defined	2024-08-13
2024-03-31	$1,388,805	29,669	+75.9%	Shares	Defined	2024-05-07
2023-12-31	$600,056	16,865	-33.6%	Shares	Defined	2024-02-14
2023-09-30	$755,097	25,390	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.